Management and monitoring of pediatric inflammatory bowel disease in the Asia-Pacific region: A position paper by the Asian Pan-Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition (APPSPGHAN) PIBD Working Group: Surgical management, disease monitoring, and special considerations.
Asia-Pacific region
complications
differentiating intestinal tuberculosis from Crohn's disease
monitoring
pediatric inflammatory bowel disease
surgery
Journal
Journal of gastroenterology and hepatology
ISSN: 1440-1746
Titre abrégé: J Gastroenterol Hepatol
Pays: Australia
ID NLM: 8607909
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
revised:
11
11
2022
received:
01
09
2022
accepted:
29
11
2022
medline:
18
4
2023
pubmed:
13
12
2022
entrez:
12
12
2022
Statut:
ppublish
Résumé
Disease phenotype of pediatric inflammatory bowel disease (PIBD) in children from the Asia-Pacific region differs from that of children from the West. Many parts of Asia are endemic for tuberculosis, making diagnosis and management of pediatric Crohn's disease a challenge. Current available guidelines, mainly from Europe and North America, may not be completely applicable to clinicians caring for children with PIBD in Asia due to differences in disease characteristics and regional resource constraints. This position paper is an initiative from the Asian Pan-Pacific Society for Pediatric Gastroenterology, Hepatology and Nutrition (APPSPGHAN) that aims to provide an up-to-date, evidence-based approach to PIBD in the Asia-Pacific region. A group of pediatric gastroenterologists with a special interest in PIBD performed an extensive literature search covering epidemiology, disease characteristics and natural history, management, and monitoring. Attention was paid to publications from the region with special consideration to a resource-limited setting. This current position paper deals with surgical management, disease monitoring, immunization, bone health, and nutritional issues of PIBD in Asia. A special section on differentiating pediatric Crohn's disease from tuberculosis in children is included. This position paper provides a useful guide to clinicians in the surgical management, disease monitoring, and various health issues in children with IBD in Asia-Pacific region.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
510-522Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2023 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
Références
Ng SC, Shi HY, Hamidi N et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet 2017; 390: 2769-2778.
Huang JG, Aw MM. Pediatric inflammatory bowel disease in Asia: Epidemiology and natural history. Pediatr Neonatol 2020; 61: 263-271.
Wang XQ, Xiao Y, Xu X et al. Study of disease phenotype and its association with prognosis of paediatric inflammatory bowel disease in China. BMC Pediatr 2018; 18: 229. https://doi.org/10.1186/s12887-018-1212-x
Tsai CH, Chen HL, Ni YH, Hsu HY, Jeng YM, Chang CJ, Chang MH. Characteristics and trends in incidence of inflammatory bowel disease in Taiwanese children. J Formos Med Assoc 2004; 103: 685-691.
de Bie CI, Paerregaard A, Kolacek S, Ruemmele FM, Koletzko S, Fell JME, Escher JC. Disease phenotype at diagnosis in pediatric Crohn's disease: 5-year analyses of the EUROKIDS Registry. Inflamm Bowel Dis 2013; 19: 378-385.
Kedia S, Das P, Madhusudhan KS et al. Differentiating Crohn's disease from intestinal tuberculosis. World J Gastroenterol 2019; 25: 418-432.
van Rheenen PF, Aloi M, Assa A et al. The medicalmManagement of paediatric Crohn's disease: An ECCO-ESPGHAN guideline update. J Crohns Colitis 2021; 15: 171-194.
Amil-Dias J, Kolacek S, Turner D et al. Surgical management of Crohn disease in children: guidelines from the Paediatric IBD Porto Group of ESPGHAN. J Pediatr Gastroenterol Nutr 2017; 64: 818-835.
Forsdick VK, Tanny SPT, King SK. Medical and surgical management of pediatric perianal Crohn's disease: A systematic review. J Pediatr Surg 2019; 54: 2554-2558.
Mattioli G, Pio L, Arrigo S, Pini Prato A, Montobbio G, Massimo Disma N et al. Cone-like resection, fistulectomy and mucosal rectal sleeve partial endorectal pull-through in pediatric Crohn's disease with perianal complex fistula. Dig Liver Dis 2015; 47: 658-662.
Dharmaraj R, Nugent M, Simpson P, Arca M, Gurram B, Werlin S. Outcomes of fecal diversion for colonic and perianal Crohn's disease in children. J Pediatr Surg 2018; 53: 472-476.
Singh S, Ding NS, Mathis KL et al. Systematic review with meta-analysis: Faecal diversion for management of perianal Crohn's disease. Aliment Pharmacol Ther 2015; 42: 783-792.
Carnovale C, Maffioli A, Zaffaroni G et al. Efficacy of tumour necrosis factor-alpha therapy in paediatric Crohn's disease patients with perianal lesions: A systematic review. Expert Opin Biol Ther 2020; 20: 239-251.
Kim S. Surgery in pediatric Crohn's disease: Indications, timing and post-operative management. Pediatr Gastroenterol Hepatol Nutri 2017; 20: 14-21.
Turner D, Ruemmele FM, Orlanski-Meyer E et al. Management of paediatric ulcerative colitis, part 2: Acute severe colitis-An evidence-based consensus guideline from the European Crohn's and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018; 67: 292-310.
Gonzalez DO, Nwomeh BC. Complications in children with ulcerative colitis undergoing ileal pouch-anal anastomosis. Semin Podiatry Sure 2017; 26: 384-390.
Turner D, Ricciuto A, Lewis A et al. STRIDE-II: An update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the International Oeganization for the Study of IBD (IOIBD): Determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology 2021; 160: 1570-1583.
Cucchiara S, D'Arcangelo G, Isoldi S et al. Mucosal healing in Crohn's disease: New insights. Expert Rev Gastroenterol Hepatol 2020; 14: 335-345.
Le Berre C, Ricciuto A, Peyrin-Birolet L, Turner D. Evolving short- and long-term goals of management of inflammatory bwel disease: Getting it right, making it last. Gastroenterology 2022; 162: 1424-1438.
Santha SL, Shankar PR, Pan A, Schoen B, Kugathasan S, Sauer CG. Mucosal healing in clinical practice: A single-center pediatric IBD experience. Inflamm Bowel Dis 2017; 23: 1447-1453.
Zubin G, Peter L. Predicting endoscopic Crohn's disease activity before and after induction therapy in children: a comprehensive assessment of PCDAI, CRP, and fecal calprotectin. Inflamm Bowel Dis 2015; 21: 1386-1391.
Carmen N, Tomalty D, Church PC et al. Clinical disease activity and endoscopic severity correlates poorly in children newly diagnosed with Crohn's disease. Gastrointest Endoc 2019; 89: 364-372.
Ziv-Baran T, Hussey S, Sladek M et al. Response to treatment is more important than disease severity at diagnosis for prediction of early relapse in new-onset paediatric Crohn's disease. Aliment Pharmacol Ther 2018; 48: 1242-1250.
Hyams J, Markowitz J, Otley A et al. Evaluation of the pediatric Crohn's disease activity index: A prospective multicenter experience. J Pediatr Gastroenterol Nutr 2005; 41: 416-421.
Turner D, Griffiths AM, Walters TD et al. Mathematical weighting of the pediatric Crohn's disease activity index (PCDAI) and comparison with its other short versions. Inflamm Bowel Dis 2012; 18: 55-62.
Ricciuto A, Fish J, Carman N et al. Symptoms do not correlate with findings from colonoscopy in children with inflammatory bowel disease and primary sclerosing cholangitis. Clin Gastroenterol Hepatol 2018; 16: 1098-105.e1091.
Turner D, Levine A, Walters TD et al. Which PCDAI version best reflects intestinal inflammation in pediatric Crohn's disease? J Pediatr Gastroenterol Nutr 2017; 64: 254-260.
Turner D, Hyams J, Markowitz J et al. Appraisal of the pediatric ulcerative colitis activity index (PUCAI). Inflamm Bowel Dis 2009; 15: 1218-1223.
Schechter A, Griffiths C, Gana JC et al. Early endoscopic, laboratory and clinical predictors of poor disease course in paediatric ulcerative colitis. Gut 2015; 64: 580-588.
Turner D, Griffiths AM, Veerman G, Johanns J, Damaraju L, Blank M, Hyams J. Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab. Clin Gastroenterol Hepatol 2013; 11: 1460-1465.
Restellini S, Chao CY, Martel M et al. Clinical parameters correlate with endoscopic activity of ulcerative colitis: A systematic review. Clin Gastroenterol Hepatol 2019; 17: 1265-1275.
Chang S, Malter L, Hudesman D. Disease monitoring in inflammatory bowel disease. World J Gastroenterol 2015; 21: 11246.
Turner D, Mack DR, Hyams J et al. C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis. J Crohns Colitis 2011; 5: 423-429.
Alper A, Zhang L, Pashankar D et al. Correlation of erythrocyte sedimentation rate and C-reactive protein with pediatric inflammatory bowel disease activity. J Pediatr Gastroenterol Nutr 2017; 65: e25-e27.
Haisma SM, Verkade HJ, Scheenstra R, van der Doef HPJ, Bodewes FAJA, van Rheenen PF. Time-to-reach target calprotectin level in newly diagnosed patients with Inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2019; 69: 466-473.
Weinstein-Nakar I, Focht G, Church P et al. Associations among mucosal and transmural healing and fecal level of calprotectin in children with Crohn's disease. Clin Gastroenterol Hepatol 2018; 16: 1089-1097.
Kolho KL, Sipponen T. The long-term outcome of anti-tumor necrosis factor-α therapy related to fecal calprotectin values during induction therapy in pediatric inflammatory bowel disease. Scand J Gastroenterol 2014; 49: 434-441.
Logan M, Clark CM, Ijaz UZ et al. The reduction of faecal calprotectin during exclusive enteral nutrition is lost rapidly after food re-introduction. Aliment Pharmacol Ther 2019; 50: 664-674.
Foster AJ, Smyth M, Lakhani A, Jung B, Brant RF, Jacobson K. Consecutive fecal calprotectin measurements for predicting relapse in pediatric Crohn's disease patients. World J Gastroenterol 2019; 25: 1266-1277.
Turner D, Ruemmele FM, Orlanski-Meyer E et al. Management of paediatric ulcerative colitis, part 1: Ambulatory care-An evidence-based guideline from European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018; 67: 257-291.
Shentova R, Baycheva M, Hadjiiski P, Kofinova D, Yaneva P. Role of fecal calprotectin as a predictor of endoscopic activity in paediatric patients with ulcerative colitis. Gastroenterol Hepatol 2020; 43: 57-61.
Kapel N, Campeotto F, Kalach N et al. Fecal calprotectin in term and preterm neonates. J Pediatr Gastroenterol Nutr 2010; 51: 542-547.
Song JY, Lee YM, Choi YJ, Jeong SJ. Fecal calprotectin level in healthy children aged less than 4 years in South Korea. J Clin Lab Anal 2017; 31: e22113.
Bernstein C, Eliakim A, Fedail S et al. World Gastroenterology Organisation global guidelines inflammatory bowel disease: Update August 2015. J Clin Gastroenterol 2016; 50: 803-818.
Anupindi SA, Podberesky DJ, Twobin AJ et al. Pediatric inflammatory bowel disease: Imaging issues with targeted solutions. Abdom Imaging 2015; 40: 975-992.
Rothrock SG, Green SM, Harding M et al. Plain abdominal radiography in the detection of acute medical and surgical disease in children: A retrospective analysis. Pediatr Emerg Care 1991; 7: 281-285.
Bruining DH, Zimmermann EM, Loftus EV Jr et al. Consensus recommendations for evaluation, interpretation, and utilization of computed tomography and magnetic resonance enterography in patients with small bowel Crohn's disease. Gastroenterology 2018; 154: 1172-1194.
Siddiki HA, Fidler JL, Fletcher JG et al. Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease. Am J Roentgenol 2009; 193: 113-121.
Towbin AJ, Sullivan J, Denson LA, Wallihan DB, Podberesky DJ. CT and MR enterography in children and adolescents with inflammatory bowel disease. Radiographics 2013; 33: 1843-1860.
Varyani F, Samuel S. Can magnetic resonance enterography (MRE) replace ileo-colonoscopy for evaluating disease activity in Crohn's disease? Best Pract Res Clin Gastroenterol 2019; 38-39: 1016-1021.
van Wassenaer EA, de Voogd FAE, van Rijn RR et al. Diagnostic accuracy of transabdominal ultrasound in detecting intestinal inflammation in paediatric IBD patient: A systematic review. J Crohns Colitis 2019; 13: 1501-1509.
Kellar A, Wilson S, Kaplan G, DeBruyn J, Tanyingoh D, Novak KL. The simple pediatric activity ultrasound score (SPAUSS) for the accurate detection of pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2019; 69: e1-e6.
Friedlander JA, Liu QY, Sahn B et al. NASPGHAN capsule endoscopy clinical report. J Pediatr Gastroenterol Nutr 2017; 64: 485-494.
Nemeth A, Agardh D, Wurm Johansson G et al. Video capsule endoscopy in pediatric patients with Crohn's disease: A single-center experience of 180 procedures. Therap Adv Gastroenterol 2018; 11: 1756284818758929.
Wu J, Huang Z, Wang Y, Tang Z, Lai L, Xue A, Huang Y. Clinical features of capsule endoscopy in 825 children: A single-center, retrospective cohort study. Medicine (Baltimore) 2020; 99: e22864.
Panes J, Bouhnik Y, Reinisch J et al. Imaging techiniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidenced-based consensus guidelines. J Crohns Colitis 2013; 7: 556-585.
Kedia S, Sharma R, Makharia G et al. Indian Guidelines on imaging of the small intestine in Crohn's disease: A Joint Indian Society of Gastroenterology and Indian Radiology and Imaging Association Consensus Statement. Indian J Radiol Imaging 2019; 29: 111-132.
Shah SC, Colombel JF, Sands BE, Narula N. Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease. Aliment Pharmacol Ther 2016; 43: 317-333.
Oliva S, Thomson M, de Ridder L et al. Endoscopy in pediatric inflammatory bowel disease: A position paper on behalf of the porto IBD Group of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018; 67: 414-430.
Oliva S, Aloi M, Viola F et al. A treat to target strategy using panenteric capsule endoscopy in pediatric patients with Crohn's disease. Clin Gastroenterol Hepatol 2019; 17: 2060-2067.
Melmed GY, Dubinsky MC, Rubin DT et al. Utility of video capsule endoscopy for longitudinal monitoring of Crohn's disease activity in the small bowel: a prospective study. Gastrointest Endosc 2018; 88: 947-955.
Miele E, Shamir R, Aloi M et al. Nutrition in pediatric inflammatory bowel disease: a position paper on behalf of the Porto Inflammatory Bowel Disease Group of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018; 66: 687-708.
Jin HY, Lim JS, Lee Y et al. Growth, puberty, and bone health in children and adolescents with inflammatory bowel disease. BMC Pediatr 2021; 21: 1-9, 35.
Song SM, Kim Y, Oh SH, Kim KM. Nutritional status and growth in Korean children with Crohn's disease: A single-center study. Gut Liver 2014; 8: 500.
Laakso S, Valta H, Verkasalo M, Toiviainen-Salo S, Makitie O. Compromised peak bone mass in patients with inflammatory bowel disease: A prospective study. J Pediatr 2014; 164: 1436-1443.e1.
Levy-Sharga Y, Shenkar A, Modan-Moses D et al. Longitudinal changes in bone mineral density in children with inflammatory bowel diseases. Acta Paediatr 2020; 109: 1026-1032.
Wong SC, Catto-Smith AG, Zacharin M. Pathological fractures in paediatric patients with inflammatory bowel disease. Eur J Pediatr 2014; 173: 141-151.
Schmidt S, Mellstrom D, Norjavaara E, Sundh V, Saalman R. Longitudinal assessment of bone mineral density in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2012; 55: 511-518.
Rozes S, Guilmin-Crepon S, Alison M et al. Bone health in pediatric patients with Crohn disease. J Pediatr Gastroenterol Nutr 2021; 73: 231-235.
Saadah OI, Annese V, Mosli MH. Prevalence and predictors of reduced bone density in children and adolescent patients with Crohn's disease. J Clin Densitom 2021; 24: 252-258.
Mosli MH, Saadah OI. Metabolic bone disease in children and adolescent patients with ulcerative colitis. J Pediatr (Rio J) 2021; 97: 242-247.
Ronel N, Tzion RL, Orlanski-Meyer E et al. Clinical criteria can identify children with osteopenia in newly diagnosed Crohn's disease. J Pediatr Gastroenterol Nutr 2021; 72: 270-275.
Sigurdsson GV, Schmidt S, Mellstrom S et al. Bone mass development from childhood into young adulthood in patients with childhood-onset inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2017; 23: 2215-2226.
Dipasquale V, Romano C. Vaccination strategies in pediatric inflammatory bowel disease. Vaccine 2017; 35: 6070-6075.
Gertosio C, Licari A, De Silvestri A, Rebuffi C, Chiappini E, Marseglia GL. Efficacy, immunogenecity, and safety of available vaccines in children on biologics: A systematic review and metaanalysis. Vaccine 2022; 40: 2679-2695.
Quan J, Ma C, Panaccione R et al. Serological responses to three doses of SARS-CoV-2 vaccination in inflammatory bowel disease. Gut 2022: gutjnl-2022-327440. https://doi.org/10.1136/gutjnl-2022-327440
Siegel CA, Melmed GY, McGovern DPB et al. SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: Recommendations from an international consensus meeting. Gut 2021; 70: 635-640.
Brooks AJ, Norman P, Peach EJ et al. Prospective study of psychological morbidity and illness perceptions in young people with inflammatory bowel disease. J Crohns Colitis 2019; 13: 1003-1011.
Rosen MJ, Dhawan A, Saeed SA et al. Inflammatory bowel disease in children and adolescents. JAMA Pediatr 2015; 169: 1053-1060.
Blum RW, Garell D, Hodgkin CH et al. Transition from child-entered to adult health-care systems for adolescents with chronic conditions: A position paper of the Society for Adolescent Medicine. J Adolesc 1993; 14: 570-576.
Fu N, Bollegala N, Jacobson K et al. Canadian consensus statements on the transition of adolescents and young adults with inflammatory bowel disease from pediatric to adult care: A collaborative initiative between the Canadian IBD Transition Network and Crohn's and Colitis Canada. J Can Assoc Gastroenterol 2022; 26: 105-115.
Mollah T, Lee D, Giles E. Impact of a new young adult inflammatory bowel disease transition clinic on patient satisfaction and clinical outcomes. J Paediatr Child Health 2022; 58: 1053-1059.
Kumagai H, Shimizu T, Iwama I et al. A consensus statement on health-care transition for childhood-onset inflammatory bowel disease patients. Pediatr Int 2022; 64: e15241.
van Rheenen PF, Aloi M, Biron IA et al. European Crohn's and Colitis Organisation Topical Review on transitional care in inflammatory bowel disease. J Crohns Colitis 2017; 11: 1032-1038.
Park DI, Hisamatsu T, Chen M et al. Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessment. J Gastroenterol Hepatol 2018; 33: 20-29.
Houben RMGJ, Dodd PJ. The global burden of latent tuberculosis infection: A re-estimation using mathematical modelling. PLoS Med 2016; 13: e1002152.
Lal SB, Bolia R, Menon JV et al. Abdominal tuberculosis in children: A real-world experience of 218 cases from an endemic region. J Gastroenterol Hepatology Open 2020; 4: 215-220.
Al Karawi MA, Mohamed AE, Yasawy MI et al. Protean manifestation of gastrointestinal tuberculosis: report on 130 patients. J Clin Gastroenterol 1995; 20: 225-232.
Banerjee R, Pal P, Mak JWY, Ng SC. Challenges in the diagnosis and management of inflammatory bowel disease in resource-limited settings in Asia. Lancet Gastroenterol Hepatol 2020; 5: 1076-1088.
World Health Organization. World Health Organization tuberculosis guidelines: recent updates. Available at: who.int/publications/digital/global-tuberculosis-report-2021 (accessed November 10, 2022).
Ng SC, Hirai HW, Tsoi KK, Wong SH, Chan FK, Sung JJ, Wu JC. Systematic review with meta-analysis: accuracy of interferon-gamma releasing assay and anti-Saccharomyces cerevisiae antibody in differentiating intestinal tuberculosis from Crohn's disease in Asians. J Gastroenterol Hepatol 2014; 29: 1664-1670.
Ramadass B, Chittaranjan S, Subramanian V, Ramakrishna BS. Fecal polymerase chain reaction for Mycobacterium tuberculosis IS6110 to distinguish Crohn's disease from intestinal tuberculosis. Indian J Gastroenterol 2010; 29: 152-156.
Kedia S, Sharma R, Sreenivas V et al. Accuracy of computed tomographic features in differentiating intestinal tuberculosis from Crohn's disease: A systematic review with meta-analysis. Intest Res 2017; 15: 149-159.
Knox C, Almeida J. The comb sign. Clinic. Gastroenterol Hepatol 2021; 19: A29-A30.
Jin T, Fei B, Zhang Y, He X. The diagnostic value of polymerase chain reaction for Mycobacterium tuberculosis to distinguish intestinal tuberculosis from Crohn's disease: A meta-analysis. Saudi J Gastroenterol 2017; 23: 3-10.
Dutta AK, Sahu MK, Gangadharan SK, Chacko A. Distinguishing Crohn's disease from intestinal tuberculosis-A prospective study. Trop Gastroenterol 2011; 32: 204-209.
Singh SK, Srivastava A, Kumari N, Poddar U, Yacha SK, Paddy CM. Differentiation between Crohn disease and intestinal tuberculosis in children. J Pediatr Gastroenterol Nutr 2018; 66: e6-e11.
Park DI, Hisamatsu T, Chen M et al. Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: Management. J Gastroenterol Hepatol 2018; 33: 30-36.
Lee CK, Wong SHV, Lui G et al. A prospective study to monitor for tuberculosis during anti-tumour necrosis factor therapy in patients with inflammatory bowel disease and immune-mediated inflammatory diseases. J Crohns Colitis 2018; 12: 954-962.
WHO Operational Handbook on Tuberculosis. Module 5: Management of Tuberculosis in Children and Adolescents. Geneva: World Health Organization, 2022 Licence: CC BY-NC-SA 3.0 IGO.
Shim TS. Diagnosis and treatment of latent tuberculosis infection due to initiation of anti-TNF therapy. Tuberc Respir Dis 2014; 76: 261-268.
Theis VS, Rhodes JM. Review article: minimizing tuberculosis during anti-tumour necrosis factor-alpha treatment of inflammatory bowel disease. Aliment Pharmacol Ther 2008; 27: 19-30.
Taxonera C, Ponferrada A, Riesta S et al. Serial tuberculin skin tests improve the detection of latent tuberculosis infection in patients with inflammatory bowel disease. J Crohns Colitis 2018; 15: 1270-1279.
Nakase H, Keum B, Ye BD, Park SJ, Koo HS, Eun CS. Treatment of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2nd Asian Organization of Crohn's and Colitis (AOCC) meeting in Seoul. Intest Res 2016; 14: 231.
Kim Y. Nationwide population-based epidemiologic study of very-early onset IBD using health-care big data, 2005-2016 Seoul, Korea: University of Ulsan; 2021.
Ishige T, Tomomasa T, Hatori R, Tatsuki M, Igarashi Y, Sekine K, Arakawa H. Temporal trend of pediatric inflammatory bowel disease: Analysis of national registry data 2004 to 2013 in Japan. J Pediatr Gastroenterol Nutr 2017; 65: e80-e82.
Ong C, Aw MM, Liwanag MJ, Quak SH, Phua KB. Rapid rise in the incidence of pediatric inflammatory bowel disease in a South-East Asian cohort in Singapore, 1994-2015. J Dig Dis 2018; 19: 395-403.